Clinical Trial Update: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of mirtazapine and folic acid for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• folic acid (folic acid)
• mirtazapine (mirtazapine)

Snippet

Sponsor: Capital Medical University | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED